Retrospective case series describing the efficacy, safety and cost-effectiveness of a vial-sharing programme for canakinumab treatment for paediatric patients with cryopyrin-associated periodic syndrome

DOI: 10.1186/s12969-019-0335-4

Keywords: Canakinumab, Cryopyrin-associated periodic syndrome (CAPS), Vial-sharing, Child, Paediatric

Full-Text   Cite this paper   Add to My Lib

Abstract:

The online version of this article (10.1186/s12969-019-0335-4) contains supplementary material, which is available to authorized users

Full-Text